Ph.D., Vice President Research & Development, Caris Life Sciences
Dr. Miglarese joined Caris Life Sciences as Vice President, Research & Development in August 2015. Prior to joining Caris, Dr. Miglarese founded OncoNex Consulting LLC and served as an advisor and interim Chief Scientific Officer for Cielo Therapeutics. Before that, he held various positions in the BioPharma sector including Chief Scientific Officer at GeneCentric Diagnostics, Vice President of Oncology Translational and Clinical Science at OSI/Astellas, Assistant Director of Translational Research at Array BioPharma and Section Head in the Department of Cancer Research at Bayer HealthCare Pharmaceuticals. Dr. Miglarese received his BS in Biology from Virginia Tech and earned his PhD from the Department of Microbiology and Immunology at the University of Virginia. He continued his post-doctoral training at Pfizer Central Research and in the Department of Dermatology at Yale University School of Medicine.
Presentation Title and Company Description
Immunotherapy Showcase: Molecular Profiling & Precision Medicine
Caris Life Sciences is an innovative biotechnology company, actively working to fulfill the promise of precision medicine through our unique and transformative platforms to help patients with cancer and other complex diseases.